We are live on ! Find out more
NBIX icon

Neurocrine Biosciences
NBIX

126 hedge funds and large institutions have $759M invested in Neurocrine Biosciences in 2013 Q2 according to their latest regulatory filings, with 126 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more call options, than puts

Call options by funds: $14.3M | Put options by funds: $9.91M

Holders
126
Holders Change
+126
Holders Change %
–
% of All Funds
4.11%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
126
Increased
–
Reduced
–
Closed
–
Calls
$14.3M
Puts
$9.91M
Net Calls
+$4.43M
Net Calls Change
+$4.43M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
51
Credit Suisse
Switzerland
$1.9M +$1.75M +142,240 New
AllianceBernstein
52
AllianceBernstein
Tennessee
$1.77M +$1.63M +132,541 New
Prudential Financial
53
Prudential Financial
New Jersey
$1.7M +$1.56M +127,227 New
California State Teachers Retirement System (CalSTRS)
54
California State Teachers Retirement System (CalSTRS)
California
$1.56M +$1.43M +116,286 New
ARTA
55
A.R.T. Advisors
New York
$1.47M +$1.35M +110,191 New
Ameriprise
56
Ameriprise
Minnesota
$1.27M +$1.17M +95,283 New
Two Sigma Investments
57
Two Sigma Investments
New York
$1.21M +$1.11M +90,238 New
D.E. Shaw & Co
58
D.E. Shaw & Co
New York
$1.19M +$1.09M +88,550 New
TA
59
Teachers Advisors
New York
$1.18M +$1.09M +88,413 New
BIM
60
Bogle Investment Management
Massachusetts
$1.09M +$997K +81,193 New
Millennium Management
61
Millennium Management
New York
$1.08M +$993K +80,819 New
NTCOC
62
Northern Trust Company of Connecticut
Connecticut
$1.08M +$990K +80,626 New
California Public Employees Retirement System
63
California Public Employees Retirement System
California
$1.01M +$928K +75,555 New
Susquehanna International Group
64
Susquehanna International Group
Pennsylvania
$983K +$903K +73,469 New
Barclays
65
Barclays
United Kingdom
$981K +$901K +73,333 New
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$947K +$869K +70,772 New
Morgan Stanley
67
Morgan Stanley
New York
$932K +$856K +69,668 New
State Board of Administration of Florida Retirement System
68
State Board of Administration of Florida Retirement System
Florida
$895K +$822K +66,876 New
PP
69
Paloma Partners
Connecticut
$855K +$785K +63,877 New
Swiss National Bank
70
Swiss National Bank
Switzerland
$835K +$767K +62,400 New
TC
71
TFS Capital
Pennsylvania
$822K +$755K +61,438 New
HI
72
HBK Investments
Texas
$788K +$724K +58,900 New
American Century Companies
73
American Century Companies
Missouri
$782K +$718K +58,448 New
DCM
74
Dupont Capital Management
Delaware
$775K +$712K +57,952 New
MLICM
75
Metropolitan Life Insurance Company (MetLife)
New York
$753K +$691K +56,263 New
1 2
3
4 5

NBIX Hedge Fund Activity: Q2 2013 in Review

126 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Neurocrine Biosciences (NBIX) for Q2 2013, worth a combined $759M.

Buyers outnumbered sellers: 126 funds opened new NBIX positions and 0 closed out — a net gain of 126 holders — while 0 added to existing stakes and 0 trimmed.

  • 126 institutional investors held Neurocrine Biosciences (NBIX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $759M of Neurocrine Biosciences stock for Q2 2013.
  • 126 funds opened new Neurocrine Biosciences positions in Q2 2013 and 0 closed out, a net change of +126 holders.

Based on aggregated 13F filings for Q2 2013.